• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B淋巴细胞中mTORC1的激活通过调节β-连环蛋白和RANKL/OPG促进破骨细胞形成。

Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.

作者信息

Xu Song, Zhang Yue, Liu Bin, Li Kai, Huang Bin, Yan Bo, Zhang Zhongmin, Liang Kangyan, Jia Chunhong, Lin Jun, Zeng Chun, Cai Daozhang, Jin Dadi, Jiang Yu, Bai Xiaochun

机构信息

State Key Laboratory of Organ Failure Research, Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.

Academy of Orthopedics in Guangdong Province, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China.

出版信息

J Bone Miner Res. 2016 Jul;31(7):1320-33. doi: 10.1002/jbmr.2800. Epub 2016 Mar 4.

DOI:10.1002/jbmr.2800
PMID:26825871
Abstract

The cytokine receptor activator of nuclear factor-κB ligand (RANKL) induces osteoclast formation from monocyte/macrophage lineage cells. However, the mechanisms by which RANKL expression is controlled in cells that support osteoclast differentiation are still unclear. We show that deletion of TSC1 (tuberous sclerosis complex 1) in murine B cells causes constitutive activation of mechanistic target of rapamycin complex 1 (mTORC1) and stimulates RANKL but represses osteoprotegerin (OPG) expression and subsequently promotes osteoclast formation and causes osteoporosis in mice. Furthermore, the regulation of RANKL/OPG and stimulation of osteoclastogenesis by mTORC1 was confirmed in a variety of RANKL-expressing cells and in vivo. Mechanistically, mTORC1 controls RANKL/OPG expression through negative feedback inactivation of Akt, destabilization of β-catenin mRNA, and downregulation of β-catenin. Our findings demonstrate that mTORC1 activation-stimulated RANKL expression in B cells is sufficient to induce bone loss and osteoporosis. The study also established a link between mTORC1 and the RANKL/OPG axis via negative regulation of β-catenin. © 2016 American Society for Bone and Mineral Research.

摘要

核因子κB受体活化因子配体(RANKL)可诱导单核细胞/巨噬细胞系细胞形成破骨细胞。然而,在支持破骨细胞分化的细胞中,RANKL表达的调控机制仍不清楚。我们发现,小鼠B细胞中结节性硬化复合物1(TSC1)的缺失会导致雷帕霉素机制靶点复合物1(mTORC1)的组成性激活,刺激RANKL表达,但抑制骨保护素(OPG)表达,随后促进破骨细胞形成并导致小鼠骨质疏松。此外,在多种表达RANKL的细胞和体内均证实了mTORC1对RANKL/OPG的调控以及对破骨细胞生成的刺激作用。机制上,mTORC1通过Akt的负反馈失活、β-连环蛋白mRNA的不稳定以及β-连环蛋白的下调来控制RANKL/OPG的表达。我们的研究结果表明,mTORC1激活刺激B细胞中RANKL的表达足以导致骨质流失和骨质疏松。该研究还通过对β-连环蛋白的负调控建立了mTORC1与RANKL/OPG轴之间的联系。© 2016美国骨与矿物质研究学会。

相似文献

1
Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.B淋巴细胞中mTORC1的激活通过调节β-连环蛋白和RANKL/OPG促进破骨细胞形成。
J Bone Miner Res. 2016 Jul;31(7):1320-33. doi: 10.1002/jbmr.2800. Epub 2016 Mar 4.
2
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.衰老会增加基质/成骨细胞诱导的破骨细胞生成,并改变小鼠体内破骨细胞前体细胞库。
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
3
Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).骨及其他组织中的核因子κB受体激活剂配体(RANKL)/核因子κB受体激活剂(RANK)/骨保护素系统(综述)
Mol Med Rep. 2015 May;11(5):3212-8. doi: 10.3892/mmr.2015.3152. Epub 2015 Jan 7.
4
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.人骨关节炎软骨下骨成骨细胞中骨保护素(OPG)和核因子κB受体激活剂配体(RANKL)的差异表达是这些疾病细胞代谢状态的一个指标。
Clin Exp Rheumatol. 2008 Mar-Apr;26(2):295-304.
5
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.曲匹地尔,一种血小板衍生生长因子拮抗剂,通过下调 NFATc1 抑制破骨细胞生成,并抑制小鼠的骨丢失。
Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.
6
Osteoclast differentiation by RANKL and OPG signaling pathways.破骨细胞通过 RANKL 和 OPG 信号通路的分化。
J Bone Miner Metab. 2021 Jan;39(1):19-26. doi: 10.1007/s00774-020-01162-6. Epub 2020 Oct 20.
7
Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.显性负性N-钙黏蛋白通过干扰RANKL的β-连环蛋白调节来抑制破骨细胞分化,而与细胞间黏附无关。
J Bone Miner Res. 2005 Dec;20(12):2200-12. doi: 10.1359/JBMR.050809. Epub 2005 Aug 8.
8
The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.成骨细胞与破骨细胞间的串扰在锶治疗中的反应:骨保护素的参与。
Bone. 2011 Dec;49(6):1290-8. doi: 10.1016/j.bone.2011.08.031. Epub 2011 Sep 9.
9
Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.柚皮苷通过 Wnt/β-连环蛋白信号通路增加假体周围膜成纤维细胞中骨保护素的表达。
J Orthop Surg Res. 2020 Dec 10;15(1):600. doi: 10.1186/s13018-020-02145-z.
10
The function and meaning of receptor activator of NF-κB ligand in arterial calcification.核因子κB受体激活剂配体在动脉钙化中的作用及意义
J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):666-671. doi: 10.1007/s11596-015-1487-1. Epub 2015 Oct 22.

引用本文的文献

1
Ejiao as a preventive agent for osteoporosis - a scoping review of current evidence.阿胶作为骨质疏松症的预防剂——当前证据的范围综述
J Orthop Surg Res. 2025 May 5;20(1):445. doi: 10.1186/s13018-025-05759-3.
2
KAT6A/YAP/TEAD4 pathway modulates osteoclastogenesis by regulating the RANKL/OPG ratio on the compression side during orthodontic tooth movement.KAT6A/YAP/TEAD4 通路通过调节正畸牙齿移动过程中受压侧的 RANKL/OPG 比值来调节破骨细胞生成。
Prog Orthod. 2024 Aug 12;25(1):29. doi: 10.1186/s40510-024-00530-6.
3
Early changes of bone metabolites and lymphocyte subsets may participate in osteoporosis onset: a preliminary study of a postmenopausal osteoporosis mouse model.
骨代谢物和淋巴细胞亚群的早期变化可能参与骨质疏松症的发生:绝经后骨质疏松症小鼠模型的初步研究。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1323647. doi: 10.3389/fendo.2024.1323647. eCollection 2024.
4
Identification of the transcriptome signatures and immune-inflammatory responses in postmenopausal osteoporosis.绝经后骨质疏松症中转录组特征及免疫炎症反应的鉴定
Heliyon. 2023 Dec 12;10(1):e23675. doi: 10.1016/j.heliyon.2023.e23675. eCollection 2024 Jan 15.
5
N-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis.N6-甲基腺苷修饰 ANLN 增强肝癌骨转移
Int J Biol Sci. 2023 Jan 22;19(4):1009-1023. doi: 10.7150/ijbs.73570. eCollection 2023.
6
Potential of natural medicines for treatment of osteoporosis: a narrative review.天然药物治疗骨质疏松症的潜力:叙述性综述。
J Tradit Chin Med. 2023 Feb;43(1):198-204. doi: 10.19852/j.cnki.jtcm.20221108.003.
7
How zoledronic acid improves osteoporosis by acting on osteoclasts.唑来膦酸如何通过作用于破骨细胞来改善骨质疏松症。
Front Pharmacol. 2022 Aug 25;13:961941. doi: 10.3389/fphar.2022.961941. eCollection 2022.
8
Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.胆固醇通过激活PI3K/AKT/mTOR信号通路抑制RANKL诱导的破骨细胞分化过程中的自噬。
Mol Biol Rep. 2022 Oct;49(10):9217-9229. doi: 10.1007/s11033-022-07747-w. Epub 2022 Jul 26.
9
Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments.类风湿关节炎中的炎症和骨代谢:关节破坏的分子机制和药物治疗。
Int J Mol Sci. 2022 Mar 6;23(5):2871. doi: 10.3390/ijms23052871.
10
Estrogen-mediated downregulation of HIF-1α signaling in B lymphocytes influences postmenopausal bone loss.雌激素介导的B淋巴细胞中低氧诱导因子-1α信号通路的下调影响绝经后骨质流失。
Bone Res. 2022 Feb 17;10(1):15. doi: 10.1038/s41413-022-00189-x.